Liberia Profile Updated in ClinRegs
August 12, 2021
The Liberia profile in ClinRegs has been reviewed and updated to include the following:
- Additional information on the responsibilities and activities Liberian Medicines and Health Products Regulatory Authority (LMHRA)’s Pharmacovigilance and Clinical Trials Unit (See Regulatory Authority topic, Timeline of Review, and Manufacturing & Import)
- Updated Guidelines on the Conduct of Clinical Trials in Liberia, which incorporates additional application submission and review requirements including updated clinical trial registry, safety reporting, data safety and monitoring board, insurance, audit, and investigational product (IP) manufacturing/import requirements (See Scope of Assessment, Clinical Trial Lifecycle topic, Insurance, Investigational Products topic, and Specimen Import & Export)
- New Guidelines for Inspectorate & Post Market Surveillance, which provides new IP manufacturing and import requirements (See Investigational Products topic)
- Various National Research Ethics Board (NREB) forms and templates, which include a new Research Protocol Template, Continuing Review Form, Exempt Human Research Consent Script Form, and Short Consent Template (See Ethics Committee, Clinical Trial Lifecycle, and Informed Consent topics)